CD200 and neoplasm: Similarly, in cutaneous squamous cell carcinoma, CD200 expression levels were associated with tumor grade and clinical stage where patients with high CD200 expression had shorter overall survival (31.3 months) relative to patients with low expression (41.9 months) [29].